The Science behind Ifenprodil and COVID -19


Dr. Mark Williams, Chief Science Officer of Algernon Pharmaceuticals Inc. (CSE: AGN | FRANKFURT: AGW |OTCQB: AGNPF) speaks about two basic lines of evidence that suggest Ifenprodil should be active in treating COVID-19 patients.

Algernon is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving them efficiently and safely into new human trials, developing new formulations and seeking new regulatory approvals in global markets.

Share via
Copy link
Powered by Social Snap